Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005)

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 1, 2008, Pages 126-132

  Nys, Sita ^a   Terporten, Peter H ^a   Hoogkamp Korstanje, Jacomina A A ^a   Stobberingh, Ellen E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial resistance surveillance; Enterobacteriaceae; Multidrug resistance; Urinary tract

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MOXIFLOXACIN; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DRUG CHOICE; GEOGRAPHIC DISTRIBUTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; TREND STUDY; URINARY TRACT INFECTION; URINE CULTURE; UROLOGY; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GEOGRAPHY; HUMANS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; TIME FACTORS; URINARY TRACT INFECTIONS; URINE;

EID: 45749142460     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn151     Document Type: Article

References (17)

1. Sahm DF, Thornsberry C, Mayfield DC et al. Multidrug-resistant urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001; 45: 1402-6.
2. Zhanel GG, Karlowsky JA, Harding GK et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 2000; 44: 1089-92.
3. Karlowsky JA, Hoban DJ, Decorby MR et al. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother 2006; 50: 2251-4.
4. Zhanel GG, Hisanaga TL, Laing NM et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27: 468-75.
5. Nys S, van Merode T, Bartelds AI et al. Urinary tract infections in general practice patients: Diagnostic tests versus bacteriological culture. J Antimicrob Chemother 2006; 57: 955-8.
6. Nys S, van Merode T, Bartelds AI et al. Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents 2006; 27: 236-41.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing - Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2007.
8. Oudhuis GJ, Verbon A, Hoogkamp-Korstanje JA et al. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from intensive care units in The Netherlands, 1998-2005. Int J Antimicrob Agents 2008; 31: 58-63.
9. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-87.
10. SWAB. NethMap 2007 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands. www.swab.nl
11. Hoogkamp-Korstanje JA, Roelofs-Willemse J. Antimicrobial resistance in Gram-negative bacteria from Intensive Care Units and Urology Services. A nationwide study in The Netherlands 1995-2000. Int J Antimicrob Agents 2003; 21: 547-56.
12. SWAB. NethMap 2004 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. www.swab.nl
13. De Francesco MA, Ravizzola G, Peroni L et al. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit 2007; 13: BR136-44.
14. Wagenlehner FM, Niemetz A, Dalhoff A et al. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000. Int J Antimicrob Agents 2002; 19: 557-64.
15. Gagliotti C, Nobilio L, Moro ML. Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. Clin Microbiol Infect 2007; 13: 328-31.
16. Wagenlehner F, Stower-Hoffmann J, Schneider-Brachert W et al. Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 2000; 15: 207-11.
17. SWAB. NethMap 2005 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. www.swab.nl